BNTX BioNTech SE

NASDAQ
$85.60

BioNTech SE (BNTX) is expected to report earnings on February 2, 2027, before the market open. The consensus earnings estimate is a loss of $1.85 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.5% since its last earnings release on November 3, 2026.

BioNTech SE Beat Expectations, Narrows Guidance
Tuesday, November 3, 2026 · 6:45 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs ($1.85) (GAAP)
Rev est $602.95M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $87.23

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioNTech SE

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

Sector

Healthcare

Industry

Biotechnology

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.